ClinicalTrials.Veeva

Menu

Exercise Testing in Diseases and Health

B

Baruch Padeh Medical Center

Status

Enrolling

Conditions

Exercise Test

Treatments

Diagnostic Test: Maximal exercise test

Study type

Interventional

Funder types

Other

Identifiers

NCT05263687
0033-17-POR

Details and patient eligibility

About

Cardiopulmonary exercise test (CPET) is a helpful tool for evaluation of aerobic exercise capacity and tolerance for variety of population. CPET provides a full assessment of the physiologic responses of the pulmonary, cardiovascular, muscular, and cellular oxidative systems to exercise. The test progression include a incremental stepwise (on treadmill) or ramp control protocol (on bike ergometer ) to exhaustion. Measurement of respiratory gas exchange i.e. oxygen uptake, carbon dioxide, minute ventilation, other variables while monitoring ECG, blood pressure, pulse oximetry and exertion perceived (Borg Scale) during an incremental test .

Aim: To compere exercise responses for maximal exercise testing with different population.

Full description

Each participants will conducted an exercise test on treadmill using Modified Bruce Protocol) or cycle ergometer. Quark CPET metabolic cart (Cosmed, Rome, Italy) will be use to collect and analysis gas exchange. 10 minute after the graded exercise test Supra maximal exercise test (SMT) will be done for 2 minutes one stage (treadmill protocol) or 10% at cycle protocol higher than highest load achieved in the incremental test.

all outcome measurement will be collected. Exercise tolerance and responses will be assess using the data of : pulmonary gas exchange; cardiovascular performance, and skeletal muscle metabolism.

Enrollment

1,000 estimated patients

Sex

All

Ages

4 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

*Patient who invited to the clinic to do incremental maximal exercise test or healthy *Participants with no known significant health problems.

Exclusion criteria

  • Acute fever
  • Acute myocardial infarction within 2 to 3 days.
  • Unstable angina not previously stabilized by medical therapy.
  • Uncontrolled cardiac arrhythmias causing symptoms or hemodynamic compromise.
  • Symptomatic severe aortic stenosis.
  • Uncontrolled symptomatic heart failure.
  • Inability to perform exercise Orthopedic impairment severely compromising exercise performance.

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

1,000 participants in 1 patient group

Exercise Test
Experimental group
Description:
maximal and anaerobic threshold cardiopulmonary parameters
Treatment:
Diagnostic Test: Maximal exercise test

Trial contacts and locations

1

Loading...

Central trial contact

Gur Mainzer, MD; Einat Kodesh, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems